SAMHSA: Meeting of the the Substance Abuse and Mental Health Services Administration's National Advisory Council

Announcement from the Substance Abuse and Mental Health Services Administration (SAMHSA) of a National Advisory Council (NAC) public meeting on January 28, 2020 to be held in person and via webinar. Agenda items include remarks from the Assistant Secretary for Mental Health and Substance Use, updates from SAMHSA Centers Directors, and discussion on clinical trends and emergency issues.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news

Related Links:

Conclusion: The use of a best practice quality improvement process resulted in improvements in workflow related to SBIRT, greater communication about SBIRT, and identification of barriers that blocked successful receipt of SBIRT.
Source: Quality Management in Healthcare - Category: Health Management Tags: Quality Management Applications Source Type: research
The theory of “disinhibition” has been very influential in psychiatry and neurology for over a century. Disinhibition has been used to explain clinical findings in many neurological and psychiatric disorders including dementia, traumatic brain injury, attention deficit hyperactive disorder, substance abuse, impulsivity in personality disorders, and neurodevelopmental disorders. In addition, disinhibition has been used as a unifying theory to link clinical observations with cognitive findings, and even cellular findings. This review discusses the origins and history of the theory of disinhibition and its strengt...
Source: The Journal of Nervous and Mental Disease - Category: Psychiatry Tags: Clinical Controversies Source Type: research
It has been nearly 2 years since I first wrote in this journal about reform efforts at the Substance Abuse and Mental Health Services Administration (SAMHSA). At that time, I described SAMHSA ’s plans to better serve Americans living with mental and s...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
The word “bipolar” has become colloquially associated with anything that changes rapidly or is unpredictable: the weather, technology, sports teams, politics, or even a teenager’s attitude. But for roughly 46 million people worldwide, being “bipolar” is far more serious than typical unpredictability, mood swings, or temperamental behavior. And, when bipolar disorder is complicated by substance use disorder (SUD), the situation can become incredibly dangerous for the individual and those around them. Recognizing the symptoms of bipolar and the complicating factors of substance use disorder is c...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Addiction Alcoholism Bipolar Recovery Substance Abuse Addiction Recovery Bipolar Disorder Detox Dual Diagnosis World Bipolar Day Source Type: blogs
__ Pear gets FDA clearance for insomnia therapeutic (MedCity News): “Pear Therapeutics received marketing authorization for its third product — a digital therapeutic intended to treat chronic insomnia. Called Somryst, the app is available by prescription only. It consists of a nine-week program that includes cognitive behavioral therapy and restricting sleep to a limited window of time … The company’s submission included data from two randomized controlled trials, including a study of 1,100 adults reporting chronic insomnia that used Somryst for nine weeks. They saw a significant reduction in insom...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Technology chronic insomnia cognitive-behavioral-therapy depression digital therapeutic FDA Pear Therapeutics precertification Somryst Source Type: blogs
This study examined patients in treatment for alcohol use disorders ( “Patients”) and their “concerned others” (COs—family and friends): (1) Did Patients' functioning differ according to COs' study participation? Among Patients with participating COs, (2) did Patients and COs agree on Patients' functioning, and (3) was Patients' functioning associated with C Os' functioning and quality of CO-Patient relationships?
Source: Journal of Substance Abuse Treatment - Category: Addiction Authors: Source Type: research
Four states have legalized medical cannabis for the purpose of treating opioid use disorder. It is unclear whether cannabinoids improve or exacerbate opioid withdrawal. A more thorough examination of cannabis and its impact on specific symptoms of opioid withdrawal is warranted.
Source: Journal of Substance Abuse Treatment - Category: Addiction Authors: Source Type: research
CONCLUSIONS: This post hoc analysis confirmed that patients with SZ + AUD had a worse illness course than patients with SZ-only and suggests that olanzapine may be associated with a longer time to first and recurrent exacerbations versus other antipsychotics in this difficult-to-treat population. Further research is needed to identify effective treatments for this important yet understudied patient population. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00014001. PMID: 32220153 [PubMed - as supplied by publisher]
Source: Journal of Clinical Psychiatry - Category: Psychiatry Tags: J Clin Psychiatry Source Type: research
No abstract available
Source: Postgraduate Obstetrics and Gynecology - Category: OBGYN Tags: Article Source Type: research
APA todaypraised Congress for approving a $2 trillion stimulus aid package to provide fiscal relief for Americans and businesses in the face of the COVID-19 pandemic. The legislation, known as the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), includes many provisions supported by APA that will enable psychiatrists and mental health care professionals to better respond to the pandemic. The relief package will now go to President Donald Trump, where he is expected to sign.“You can’t have a healthy economy without healthy people—and that includes mental health,” said APA President Bru...
Source: Psychiatr News - Category: Psychiatry Tags: 42 CFR Part II and Economic Security Act Bruce Schwartz CARES Act Congress coronavirus Coronavirus Aid COVID-19 Medicare Relief samhsa Saul Levin stimulus package substance use disorders telehealth Source Type: research
More News: Emergency Medicine | Men | Rural Health | Substance Abuse | Substance Abuse Disorders